Needle Free Injection Systems Market by Product, Technology & Usability - 2021

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=165815861

Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.

Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016. The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.

Based on the end user, the market is segmented into Hospitals and Clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and other end user. The hospitals and clinics segment is expected to grow at the highest rate in the forecast period.  The growth in this segment can primarily be attributed to the advancement in the medication or drug delivery technology and rising geriatric population.

Based on the type, the market is segmented into Liquid-based, projectile-based, powder-based needle-free injectors. The liquid-based needle-free injectors segment is projected to be the fastest-growing segment during forecast period in 2016. The advantages of this mode of delivery have drawn the attention of a number of market players.


The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While North America is expected to dominate the market in 2016, Europe is expected to grow at the highest CAGR during the forecast period.  The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe

Key players in the needle-free injection system market include  Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

Press Release: https://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp

Source: https://www.prnewswire.com/news-releases/needle-free-injection-system-market-worth-2017-billion-usd-by-2021-603775326.html

Medical Device Reprocessing Market by Product & Application - 2022

The global medical device reprocessing market is projected to reach USD 1,754.0 Million by 2022 from USD 823.5 Million in 2017, at a CAGR of 16.3%. The growth of this market is majorly driven by the increased utilization of the low priced reprocessed medical devices as compared to new devices, increased efforts towards reducing regulated medical waste (RMW), and rising number of surgical procedures associated with the growing prevalence of chronic diseases. However, the risk of transmission of surgical site infections associated with the use of reprocessed devices may hinder the growth of the market to a certain extent.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=583

The reprocessing practices are regulated by various regional regulatory authorities. The changing regulatory scenario favoring medical device reprocessing in a number of countries, such as France and Japan, will open up new areas of opportunity for market players. For example, till 2016, the outsourcing of medical device reprocessing was prohibited in France; however, the European Union (EU) Regulations (Article 17), released on April 5, 2017, mandated the use of third-party reprocessing services by all French hospitals. These regulations are expected to be implemented in France by 2020. Similarly, Japan does not currently have any regulations for the reprocessing of single-use medical devices. Therefore, regulatory authorities, such as the Ministry of Health, Labor and Welfare (MHLW) (Japan), in collaboration with the FDA (U.S.), are focusing on generating new medical device reprocessing guidelines for Japan.

The report analyzes the medical device reprocessing market by product & service, type of medical device, application, and region. On the basis of product & service, the reprocessing support and services segment accounted for the largest share in 2016, owing to the increased adoption of third-party reprocessing services over in-house reprocessing services by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations. Based on type of medical device, the catheters segment accounted for the largest share in 2016 and is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increased utilization of reprocessed cardiac catheters, electrophysiology catheters, and diagnostic catheters in recent years. Based on application, the market is further categorized into cardiology; gastroenterology, urology, and gynecology; arthroscopy and orthopedic surgery; and general surgery and anesthesia. In 2016, the cardiology segment accounted for the largest share of the market; this is primarily attributed to the increasing number of cardiology surgeries associated with the growing prevalence of cardiovascular diseases (CVD) across the globe.

Geographically, the global medical device reprocessing market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the market, and this is primarily attributed to its well-established healthcare industry, growing prevalence of chronic diseases, and increasing volume of surgical procedures. The European region is expected to witness the highest CAGR during the forecast period, owing to the rising prevalence of chronic diseases, increasing geriatric population, rising healthcare expenditure, increasing number of surgical procedures, and growing awareness about the usage of reprocessed medical devices

In 2016, Stryker Corporation (U.S.) and Johnson & Johnson (U.S.) dominated the global medical device reprocessing market. Some of the other players competing in this market are Vanguard AG (Germany), Medline ReNewal (U.S.), Medtronic plc (Ireland), SteriPro Canada, Inc. (Canada), Pioneer Medical Devices AG (Germany), Vascular Solutions, Inc. (U.S.), HYGIA Health Services, Inc. (U.S.), ReNu Medical, Inc. (U.S.), SureTek Medical (U.S.), and Centurion Medical Products Corporation (U.S.).

Press Release: https://www.marketsandmarkets.com/PressReleases/medical-device-reprocessing.asp

Source : https://www.prnewswire.com/news-releases/english-releases/medical-device-reprocessing-market-worth-1754-million-usd-by-2022-629366473.html

Non Invasive Prenatal Testing (NIPT) Market by Instruments, Application & End User - 2021

The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.

The market in this report is segmented on the basis of product, method, application, end user, and region. Based on product, the market is segmented into consumables and instruments. The consumable segment is further divided into assay kits & reagents and disposables. The instruments segment is divided into ultrasound device, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=145607690

Based on method, the market is further divided into ultrasound detection, biochemical screening tests, fetal cells in maternal blood tests, and cell-free DNA in maternal plasma tests. In 2016, the ultrasound detection accounted for the largest share of the market. However, the cell-free DNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. This is mainly attributed to the increasing demand for cf-DNA based techniques in NIPT testing and rising government initiatives to provide prenatal services.

Based on application, the market is divided into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest and fastest-growing application segment of the global market. This is mainly attributed to the rising incidence of chromosomal abnormalities with increasing maternal age.

Based on end user, the market is segmented into diagnostic laboratories and hospitals. In 2016, the diagnostic laboratories segment accounted for the largest share of the market. Growth in this end-user segment can be attributed to the rising incidence of chromosomal abnormalities and increasing initiatives by companies to provide advanced products in NIPT to diagnostic laboratories.

The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The market in Asia is expected to grow at the highest CAGR during the forecast period. Factors such as increasing awareness programs, high incidence of genetic disorders, increasing healthcare infrastructure, and rising disposable income are some of the factors contributing to the growth of the market in Asia.

Key market players are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

Press Release: http://www.marketsandmarkets.com/PressReleases/non-invasive-prenatal-testing.asp

Source : https://www.informazione.it/c/93FDE744-0C97-489F-82B9-49A640285894/Non-Invasive-Prenatal-Testing-NIPT-Market-Worth-2-88-Billion-USD-by-2021

IV Equipment Market by Product & End User - 2022

The global IV equipment market is projected to reach USD 13.63 Billion by 2022, at a CAGR of 6.2% from 2017 to 2022. The market growth can be attributed to a number of factors such as increasing incidence of chronic diseases, rising geriatric population, growing number of surgical procedures performed, rising number of needlestick injuries, and rising demand for ambulatory infusion pumps.

In this report, the global IV equipment market is segmented on the basis of product, end user, and region. Based on product, the market is segmented into IV catheters, administration sets, infusion pumps, securement devices, stopcocks & check valves, drip chambers, needleless connectors, and other IV equipment (luer adapters, cannula, capping systems, spikes, needles, clamping systems, and IV stands). In 2016, IV catheters accounted for the largest share of the global IV equipment market. The increasing prevalence of chronic diseases and the growing number of surgical procedures contributes to their largest share in the market.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=78345313

On the basis of end user, the market is classified into hospitals & clinics, home care, and ambulatory care centers. In 2016, the hospitals segment accounted for the largest share of the market. This can largely be attributed to the strong financial capabilities of hospitals for purchasing high-priced IV devices as well as the availability of trained professionals to operate them.

In 2016, North America accounted for the largest share of the global IV equipment market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. This large share of the North American region can be attributed to the rising geriatric population, increasing prevalence of chronic diseases, the presence of a well-established healthcare industry, growing demand for advanced medical treatments, the presence of major players, and increasing government healthcare expenditure.

The Asia-Pacific region is expected to witness the highest growth in the forecast period. Factors such as the presence of a large patient pool, rising geriatric population, growing utilization of technologically advanced IV products, increasing focus on home healthcare, growing healthcare expenditure, rapidly developing healthcare infrastructure, and increasing per capita income are driving the growth of the IV equipment market in the Asia-Pacific region.

Patient safety risks and medication errors associated with infusion pumps leading to product recalls are expected to hinder the growth of this market.

The major players in the IV equipment market are Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (U.S.), Smiths Medical (U.K.), Moog, Inc. (U.S.), Terumo Corporation (Japan.), C. R. Bard, Inc. (U.S.), and AngioDynamics, Inc. (U.S.).

Press Release : https://www.marketsandmarkets.com/PressReleases/iv-equipment.asp

Source : https://www.prnewswire.com/news-releases/iv-equipment-market-worth-1363-billion-usd-by-2022-625501283.html

Medical Connectors Market by Product & Application- 2021

The report "Medical Connectors Market by Product (Flat Silicone, Hybrid, Embedded, Radio Frequency, Push-Pull), Application (Patient Monitoring, Electrosurgery, Endoscopy, Diagnostic Imaging, Respiratory, Dental Device) & by End User - Global Forecast to 2021", report provides a detailed overview of the major drivers, restraints, trends, opportunities, and strategies impacting the medical connectors market along with the estimates and forecasts of the revenue and market share analysis.         

Browse 65 market data tables and 42 figures spread through 132 pages and in-depth TOC on "Medical Connectors Market by Product (Flat Silicone, Hybrid, Embedded, Radio Frequency, Push-Pull), Application (Patient Monitoring, Electrosurgery, Endoscopy, Diagnostic Imaging, Respiratory, Dental Device) & by End User - Global Forecast to 2021"

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=81731061

Early buyers will receive 10% customization on reports.

The medical connectors market is projected to reach USD 2.69 Billion by 2021 from USD 1.63 Billion in 2016, at a CAGR of 10.5%. The major factors driving the growth of this market are increasing incidence and prevalence of chronic diseases, rapid growth in the medical devices market, and growth in the home healthcare market, which results in increased adoption of miniaturized connectors and growing healthcare expenditure across the globe.

The medical connectors market is segmented based on products, application, end user, and region in this report. On the basis of products, the market is segmented into flat surgical silicone cables, embedded electronics connectors, radio-frequency connectors, disposable plastic connectors, hybrid circular connectors & receptacle system, power cords with retention system, lighted hospital-grade cords, magnetic medical connectors, and push-pull connectors. The flat surgical silicone cables segment is expected to grow at the highest CAGR during the forecast period. Increasing awareness about the application of connectors and its technical features are the factors driving the growth of this segment.

By application, the market is classified into cardiology devices, diagnostic imaging devices, electrosurgical instruments, patient monitoring devices, endoscopy devices, respiratory devices, analyzers and processing instruments, dental instruments, neurology devices, enteral devices, and other applications. The patient monitoring devices segment is expected to grow at the highest CAGR during the forecast period due to increasing incidence of chronic diseases and increasing adoption of patient monitoring devices.

Based on end user, the market is classified into hospitals & clinics, diagnostic laboratories and imaging centers, ambulatory surgical centers, and other end users. The hospitals & clinics end user segment is expected to grow at the highest CAGR during the forecast period due to factors such as increasing demand for electrosurgical therapy and growing incidence of chronic disorders.

Medical Connectors Market

On the basis of region, North America accounted for the largest share in the market in 2016. However, in the coming five years, growth in the market is expected to be centered on Asia. The increasing prevalence and incidence rate of chronic disorders in Asia provides growth opportunities to players in the market. Key players are focusing on strategies such as product launches, acquisitions, and expansions to strengthen their foothold in the market.

Key players in the market include Amphenol Corporation (U.S.), Delphi Automotive LLP. (U.K.), Esterline Corporation (U.S.), ITT Corporation (U.S.), Smiths Interconnect (U.K.), TE Connectivity Ltd. (Switzerland), Fisher Connectors (Switzerland), Lemo S.A. (Switzerland), Molex (U.S.), and Samtec (U.S.).

Press Release: https://www.marketsandmarkets.com/PressReleases/medical-connector.asp

Source : https://www.prnewswire.com/news-releases/medical-connectors-market-worth-269-billion-usd-by-2021-621448433.html

Pharmaceutical Robots Market by Type & by Application - 2021

The report "Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges.

Browse 98 market data tables and 40 figures spread through 141 pages and in-depth TOC on "Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021"

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=210985096

Early buyers will receive 10% customization on reports.

This report studies the global pharmaceutical robots market for the forecast period of 2016 to 2021. This market is expected to reach USD 119.5 Million by 2021 from USD 64.4 Million in 2016, at a CAGR of 13.2% during the forecast period. The key factor driving the growth of the market is the benefits offered by robotic systems in pharmaceutical manufacturing.

The global pharmaceutical robots market is segmented on the basis of type, application, and region.

Based on type, the market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. The traditional robots segment is further categorized into articulated, SCARA (selective compliance articulated robot arm), delta/parallel, Cartesian, and other robots (which include spherical and dual-arm robots). The articulated robots segment accounted for the largest share of the global pharmaceutical traditional robots market in 2016.

On the basis of application, the global pharmaceutical robots market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. In 2016, the picking and packaging segment accounted for the largest share of the global pharmaceutical robots market. Factors such as demand for personalized packaging configurations and advantages of robots in pharmaceutical manufacturing such as high speed, accuracy, ability to track and trace, error-free operation, fewer accidents, and better utilization of the floor space are contributing to the large share of the picking and packaging segment.

Pharmaceutical Robots Market

Based on region, the pharmaceutical robots market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, Asia-Pacific accounted for the largest share of the global market. This segment is also projected to register the highest CAGR of 14.1% during the forecast period. Factors such as the increase in domestic industrial robot companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investment and funding in the robots industry, and Japan’s Robot Strategy are driving the growth of the APAC pharmaceutical robots market.

Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan) are the prominent players in the global pharmaceutical robots market.

Press Release: https://www.marketsandmarkets.com/PressReleases/pharmaceutical-robot.asp

Source: https://www.prnewswire.com/news-releases/pharmaceutical-robots-market-worth-1195-million-usd-by-2021-619683983.html